Latest Advances

  • Condition: Vascular Dementia (VD) after Cerebral Infarction
  • Journal: Pakistan journal of pharmaceutical sciences
  • Treatment Used: Piracetam with Nimodipine
  • Number of Patients: 98
  • Published —
This study investigated the effects of piracetam with nimodipine in the treatment of patients with vascular dementia (VD) after cerebral infarction (stroke).
  • Condition: Steroid Refractory Lower Gastrointestinal Tract Graft-Versus-Host Disease
  • Journal: Transplantation and cellular therapy
  • Treatment Used: Vedolizumab
  • Number of Patients: 20
  • Published —
This study evaluated outcomes of patients with steroid-refractory (SR) lower gastrointestinal (LGI) acute graft-versus-host disease (aGVHD) treated with vedolizumab.
  • Condition: Dementia and Vascular Cognitive Impairments
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Donepezil and Galantamine
  • Number of Patients: 4373
  • Published —
The study aimed to understand the safety and effective for using Donepezil and Galantamine to treat vascular dementia and other vascular cognitive impairments.
  • Condition: Vascular Dementia
  • Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
  • Treatment Used: Compound Danshen Injection Combined with Western Medicine
  • Number of Patients: 588
  • Published —
In this study, researchers evaluated the safety and effectiveness of using a Compound Danshen Injection combined with Western medicine for the treatment of vascular dementia.
  • Condition: Vascular Dementia
  • Journal: Cellular and molecular biology (Noisy-le-Grand, France)
  • Treatment Used: Dengzhan Shengmai Capsule combined with Butylphthalide Soft Capsule
  • Number of Patients: 123
  • Published —
This study tested the safety and efficacy of using a dengzhan shengmai capsule combined with a butylphthalide soft capsule to treat patients with vascular dementia.
  • Condition: Strokes from Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
  • Journal: Clinical neuropharmacology
  • Treatment Used: Lomerizine Hydrochloride
  • Number of Patients: 30
  • Published —
This study tested the safety and efficacy of using lomerizine hydrochloride to prevent strokes in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
  • Condition: Vascular Dementia
  • Journal: Medicine
  • Treatment Used: Scalp Electroacupuncture with Memantine
  • Number of Patients: 150
  • Published —
This study tested the safety and efficacy of using scalp electroacupuncture combined with memantine to treat patients with vascular dementia.
  • Condition: Large B-Cell Lymphoma
  • Journal: Blood advances
  • Treatment Used: Axicabtagene Ciloleucel (axi-cel)
  • Number of Patients: 100
  • Published —
This study analyzed patients with relapsed or refractory large B-cell lymphoma (LBCL) treated with standard of care axicabtagene ciloleucel (axi-cel).
  • Condition: Reversible Posterior Leukoencephalopathy Syndrome (RPLS) due to Adrenal Pheochromocytoma
  • Journal: Medicine
  • Treatment Used: Surgery
  • Number of Patients: 1
  • Published —
This case report describes a 27-year-old male patient diagnosed with reversible posterior leukoencephalopathy syndrome (RPLS) due to adrenal pheochromocytoma treated with surgery and two weeks of ?-blockers and ?-blockers.
  • Condition: Systemic Lupus Erythematosus (SLE) in Antinuclear Antibody (ANA)-Negative Adolescent Female
  • Journal: Pediatric rheumatology online journal
  • Treatment Used: Cyclophosphamide and Rituximab
  • Number of Patients: 1
  • Published —
This case report describes an antinuclear antibody (ANA)-negative Hispanic adolescent female diagnosed with systemic lupus erythematosus (SLE) treated with cyclophosphamide and rituximab.
  • Condition: Neurological Manifestations in Covid-19
  • Journal: Neurology India
  • Treatment Used: Intravenous Immunoglobulin
  • Number of Patients: 0
  • Published —
This article presents the spectrum of neurological manifestations in COVID-19.
  • Condition: Hemophagocytic Lymphohistiocytosis
  • Journal: Journal of clinical immunology
  • Treatment Used: Hematopoietic Stem Cell Transplantation
  • Number of Patients: 38
  • Published —
The study researched hemophagocytic lymphohistiocytosis.
Showing 1-12 of 54